You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 9, 2025

Drug Price Trends for ARMODAFINIL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ARMODAFINIL

Average Pharmacy Cost for ARMODAFINIL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ARMODAFINIL 200 MG TABLET 00781-8045-31 0.62079 EACH 2025-01-22
ARMODAFINIL 150 MG TABLET 65862-0806-30 0.61655 EACH 2025-01-22
ARMODAFINIL 200 MG TABLET 00093-3093-56 0.62079 EACH 2025-01-22
ARMODAFINIL 150 MG TABLET 00093-3092-56 0.61655 EACH 2025-01-22
ARMODAFINIL 150 MG TABLET 69339-0178-03 0.61655 EACH 2025-01-22
ARMODAFINIL 150 MG TABLET 00378-3432-93 0.61655 EACH 2025-01-22
ARMODAFINIL 150 MG TABLET 00781-8037-31 0.61655 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for ARMODAFINIL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
ARMODAFINIL 200MG TAB Sandoz, Inc. 00781-8045-31 30 0.93 0.03100 EACH 2024-01-01 - 2028-08-14 FSS
ARMODAFINIL 250MG TAB Sandoz, Inc. 00781-8053-31 30 5.51 0.18367 EACH 2023-08-15 - 2028-08-14 FSS
ARMODAFINIL 50MG TAB Sandoz, Inc. 00781-8029-31 30 0.48 0.01600 EACH 2023-08-15 - 2028-08-14 FSS
ARMODAFINIL 250MG TAB Sandoz, Inc. 00781-8053-31 30 6.97 0.23233 EACH 2024-01-01 - 2028-08-14 FSS
ARMODAFINIL 50MG TAB Sandoz, Inc. 00781-8029-31 30 4.59 0.15300 EACH 2024-01-01 - 2028-08-14 FSS
ARMODAFINIL 150MG TAB Sandoz, Inc. 00781-8037-31 30 4.15 0.13833 EACH 2023-08-15 - 2028-08-14 FSS
ARMODAFINIL 150MG TAB Sandoz, Inc. 00781-8037-31 30 4.99 0.16633 EACH 2024-01-01 - 2028-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Armodafinil Market Analysis and Price Projections

Introduction

Armodafinil, a wakefulness-promoting agent, is widely used to treat narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder. The drug has gained significant traction due to its effectiveness in enhancing alertness and cognitive function. Here, we delve into the market analysis and price projections for Armodafinil, highlighting key trends, drivers, and challenges.

Market Size and Growth

The global Armodafinil market is experiencing robust growth, driven by increasing awareness of sleep disorders and a rising demand for effective treatments. The market is projected to exhibit a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031[2].

Global Market Size

As of 2023, the global Armodafinil market size was valued at a significant figure, with projections indicating continued growth. The market is segmented into various regions, each contributing to the overall growth trajectory.

Regional Analysis

  • North America: The Armodafinil market in North America is valued at approximately $1.5 billion, growing at a CAGR of 7%. Key players include Cephalon, a subsidiary of Teva Pharmaceuticals, and generics from Mylan and Sandoz. The region's well-established healthcare infrastructure and rising awareness of sleep apnea are significant drivers[2].
  • Europe: The European market is estimated at $800 million, with a growth rate of 6% CAGR. Major players include Cephalon and generics from companies like Ratiopharm and Sandoz. Country-specific regulations and healthcare policies significantly influence market dynamics, especially in Germany and the U.K.[2].
  • Asia-Pacific: This region is projected to reach $500 million, growing at a robust 10% CAGR. Key players include Hikma Pharmaceuticals and local generics. Rising awareness of sleep disorders and cognitive enhancement is driving demand, particularly in developed regions like Japan and Australia[2].
  • Latin America: The market in Latin America is valued at around $250 million, with a growth rate of 8% CAGR. Demand is driven by a growing recognition of sleep disorders and an increasing desire for cognitive performance enhancement among young professionals[2].
  • Middle East & Africa: This region is estimated at $150 million, growing at a rate of 9% CAGR. Key players include local generic manufacturers and some multinational pharmaceuticals. Increasing awareness of mental health and sleep disorders in urban areas is a significant factor[2].

Market Drivers

Several factors are driving the growth of the Armodafinil market:

Increasing Awareness of Sleep Disorders

The rising awareness of sleep disorders such as narcolepsy, OSA, and shift work sleep disorder is a major driver. As more people seek medical help for these conditions, the demand for Armodafinil increases[2].

Growing Demand for Cognitive Enhancement

The trend of cognitive enhancement in professional environments has led to a wider acceptance of Armodafinil. This is particularly evident among shift workers and individuals experiencing lifestyle-induced fatigue[2].

Product Innovation and Strategic Collaborations

Pharmaceutical companies are focusing on product innovation and strategic collaborations, which are further fueling market expansion. The advent of generic versions has made the drug more accessible and cost-effective[2].

Technological Advancements

Technological advancements in drug formulation and delivery methods are expected to enhance the product's appeal to a broader audience. This includes the rise of telemedicine and personalized medicine opportunities[2].

Market Challenges

Despite the growth, the Armodafinil market faces several challenges:

Stringent Regulatory Approvals

Stringent regulatory approvals can hinder the growth of the market. Regulatory bodies often impose strict guidelines, which can delay the approval process for new formulations or generic versions[2].

Potential Side Effects

Armodafinil, like any other medication, has potential side effects, which can deter some patients. This includes headaches, nausea, and dizziness, among others[5].

Alternative Treatments

The presence of alternative treatments for sleep disorders and cognitive enhancement can also slow adoption rates. Patients may opt for other medications or non-pharmacological treatments[2].

Competitive Landscape

The Armodafinil market is characterized by a few key players, including:

  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Cadila
  • Torrent Pharmaceuticals Ltd.
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd.
  • Aurobindo Pharma Ltd.[4]

These companies are adopting various strategies such as collaborations with government, new product innovations, and technological advancements to stay competitive.

Price Projections

The cost of Armodafinil can vary significantly depending on the region, pharmacy, and whether the patient opts for the brand name or generic version.

Retail Prices

The average retail price for 30 tablets of 250mg Armodafinil is around $619.71. However, using discount cards or opting for generic versions can significantly reduce the cost. For example, a generic version can cost as low as $34.84 for 30 tablets[5].

Regional Price Variations

Prices vary across different regions and pharmacies. For instance, in North America, prices can range from $339.00 at Walmart to $656.10 at Walgreens for the same dosage and quantity[5].

Market Segmentation

The Armodafinil market is segmented based on several factors:

By Application

  • Narcolepsy
  • Obstructive Sleep Apnea/Hypopnea Syndrome
  • Shift Work Sleep Disorder
  • Other Applications[4]

By Route of Administration

  • Oral[4]

By Dosage Form

  • Tablets[4]

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies[4]

Emerging Trends and Opportunities

Several emerging trends and opportunities are shaping the Armodafinil market:

Off-Label Uses

Armodafinil is increasingly being used for off-label purposes, such as treating attention deficit hyperactivity disorder (ADHD) and in military settings. This expands the market potential beyond traditional indications[2].

Telehealth and E-commerce

The rise of telehealth services and e-commerce platforms for medicine distribution is making Armodafinil more accessible. This trend is particularly significant in regions with limited healthcare infrastructure[2].

Mental Health Awareness

The growing focus on mental health and productivity enhancement is driving interest in Armodafinil. As more individuals seek prescription-based cognitive enhancers, the market is expected to grow further[2].

Key Takeaways

  • The global Armodafinil market is projected to grow at a CAGR of 4.50% from 2024 to 2031.
  • Increasing awareness of sleep disorders and the growing trend of cognitive enhancement are key drivers.
  • The market faces challenges such as stringent regulatory approvals and potential side effects.
  • Major players are adopting strategies like product innovation and strategic collaborations to stay competitive.
  • Regional prices vary significantly, with generic versions offering cost-effective alternatives.
  • Emerging trends include off-label uses, telehealth, and e-commerce, which are expected to drive further growth.

FAQs

What is Armodafinil used for?

Armodafinil is used primarily to treat narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder, enhancing alertness and cognitive function.

What is the projected CAGR of the Armodafinil market from 2024 to 2031?

The Armodafinil market is projected to exhibit a robust CAGR of 4.50% during the forecast period from 2024 to 2031[2].

Which regions are driving the growth of the Armodafinil market?

North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa are the key regions driving the growth of the Armodafinil market, each with unique growth rates and market dynamics[2].

What are the main challenges facing the Armodafinil market?

The main challenges include stringent regulatory approvals, potential side effects, and the presence of alternative treatments for sleep disorders and cognitive enhancement[2].

How does the cost of Armodafinil vary?

The cost of Armodafinil varies significantly depending on the region, pharmacy, and whether the patient opts for the brand name or generic version. Generic versions are generally more cost-effective[5].

What emerging trends are shaping the Armodafinil market?

Emerging trends include off-label uses, the rise of telehealth services, and the increase in e-commerce platforms for medicine distribution, which are making Armodafinil more accessible and driving further growth[2].

Sources

  1. Cognitivemarketresearch.com: Armodafinil Market Report 2024 (Global Edition)
  2. OpenPR.com: Comprehensive Market Forecast for Armodafinil
  3. PBS.gov.au: Armodafinil: predicted versus actual analysis
  4. OpenPR.com: Armodafinil Market Business Growth, Trends, and Challenges
  5. SingleCare.com: Armodafinil Coupons & Prices

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.